Skip to main content

Table 4 Comparison of laboratory values at admission and peak value during the hospital stay comparing subjects who did and did not use cannabis

From: Cannabis consumption is associated with lower COVID-19 severity among hospitalized patients: a retrospective cohort analysis

aLab values, median [IQR]

Active cannabis users

Non-users

P value

White blood cell total count (109/L)

 Admission

6.54 [4.85, 9.44]

6.34 [4.36, 9.37]

0.691

 Peak value

9.7 [6.8, 13.6]

10.8 [7.6, 15.3]

0.069

Absolute lymphocyte count (109/L)

 Admission

1.41 [0.73, 2.00]

0.86 [0.57, 1.31]

< .001

 Peak value

2.01 [1.37, 2.70]

1.67 [1.17, 2.25]

0.020

Absolute neutrophil count (109/L)

 Admission

4.69 [2.87, 6.63]

4.56 [2.93, 7.32]

0.556

 Peak value

6.72 [4.74, 10.21]

7.98 [5.37, 11.99]

0.029

Interleukin 6 (IL-6), pg/mL

 Admission

2.5 [2.0, 6.9]

6.7 [2.0, 17.7]

0.108

 Peak value

2.5 [2.0, 15.7]

7.5 [2.5, 21.6]

0.120

C-reactive protein (CRP), mg/dL

 Admission

3.7 [0.6, 6.0]

7.6 [3.0, 13.3]

< .001

 Peak value

3.4 [0.8, 8.3]

9.6 [4.2, 16.0]

< .001

Serum ferritin, ng/mL

 Admission

282 [156, 519]

622 [293, 1,262]

0.001

 Peak value

287 [125, 645]

778 [347, 1,690]

< .001

D-dimer, ng/mL

 Admission

468 [401, 1,549]

1,140 [671, 2,073]

0.017

 Peak value

521 [399, 1,896]

1,628 [947, 4,351]

0.001

Serum procalcitonin, ng/mL

 Admission

0.10 [0.10, 0.12]

0.15 [0.10, 0.39]

0.001

 Peak value

0.10 [0.10, 0.20]

0.19 [0.10, 0.64]

0.006

  1. IQR interquartile range
  2. aWilcoxon rank sum test